All your tissue suppliers.
One real-time exchange.
AlloPort lets surgical purchasers see live inventory across every participating tissue bank in one place — and gives accredited tissue banks direct access to the surgical supply chain without traditional distribution. We list inventory and process orders. Tissue Banks keep custody and ship directly.
AATB-accredited, FDA-registered tissue banks only · All purchasers vetted and qualified · No cost to your facility
ILLUSTRATIVE INTERFACE — SAMPLE DATA
- AATB-accredited, FDA-registered tissue banks
- Fully vetted surgical purchasers
- Never in the chain of custody
- Immutable audit log on every action
See the market working.
A short walkthrough of what purchasers see when they search across participating tissue banks, how an order moves, and why the graft never passes through us.
AlloPort connects your surgical purchasers directly with accredited tissue banks — without cost to your facility.
Vendor consolidation gave purchasing tunnel vision.
When a facility's sourcing narrows to a handful of contracted suppliers, new and regional tissue banks lose any practical route to reach it — especially across state lines. Supply gets thinner, choice gets narrower, and grafts sit on shelves in one region while another region goes looking.
Reaching buyers takes a sales force
- Placement requires multiple layers of sales professionals and manual procurement coordination.
- Purchasers can only buy what their existing vendors happen to carry.
- Tissue Banks outside a region have almost no way to be discovered by facilities inside it.
- Availability is quoted and confirmed by phone and email, not seen.
- Nobody has market-level data, so inventory and pricing decisions are made on instinct.
Discovery without displacing anything
- Procurement keeps buying from its approved, contracted tissue banks — and can discover new ones alongside them.
- Real-time inventory across participating tissue banks, in a single searchable view.
- Automated customer communication and product education replaces layers of manual coordination.
- A tissue bank of any size can be found by a qualified buyer in any region.
- Quarterly market analytics turn placement into an evidence-based decision.
We move the order. Tissue Banks move the grafts.
AlloPort is not a distributor and is never involved in the chain of custody. That keeps the regulatory chain short, the accountability clear, and the relationship between the tissue bank and facility intact.
1 · Tissue Bank lists
Your inventory system connects to AlloPort, so stock levels, sizes and graft identifiers stay current automatically.
2 · Purchaser orders
A vetted buyer searches across participating tissue banks, sees what is actually in stock, and places the order.
3 · Tissue Bank ships direct
The tissue bank fulfils from its own inventory, under its own custody, straight to the facility.
AlloPort never takes custody. Tissue moves once — from the accredited tissue bank that recovered and processed it, straight to the facility that will implant it. One handoff, one chain of custody, one party accountable for the graft.
Live availability
Listings reflect what the tissue bank actually has on the shelf right now, not last quarter's catalog.
Your own sales page
Every tissue bank maintains its own storefront, credentials, and marketing materials on the platform.
Built-in product education
An AI layer surfaces product features, instructions for use, and company literature to buyers at the point of decision.
Less waste
Wider, faster discovery means fewer grafts reaching their expiry date before a patient needs them.
Built around what each side actually needs.
AlloPort was developed from a close reading of both sides of this market: tissue banks that need a route to buyers, and procurement managers who need speed, compliance confidence, and transparent availability.
A new commercial channel, without a new sales force.
Direct access to the surgical supply chain, better economics than traditional distribution, and the market data to decide what to produce next. Open to AATB-accredited, FDA-registered tissue banks of any size.
Start onboardingReach buyers beyond your region
Qualified purchasers in any state can find your inventory — the discovery route consolidation took away.
You keep custody and control
Tissue never leaves your facility until it ships to the implanting site. No consignment, no re-warehousing, no third party handling your grafts.
Better economics than distribution
A small processing fee replaces layers of sales professionals and manual coordination — keeping margin in R&D, acquisitions, and capital improvements.
Your own page, credentials and materials
Present your tissue bank properly: your literature, your product features, your instructions for use — not a line item in someone else's catalog.
You control what's visible
You decide what is listed, what is featured, and what is sequestered. Only non-confidential inventory data is ever accessed.
Keep your existing inventory system
AlloPort integrates directly into your existing inventory system. We do the heavy lifting when it comes to data management.
Speed, compliance confidence, transparent availability.
Procurement managers do not want complexity. Search, locate, order — and keep every existing supplier relationship exactly as it is. There is no cost to your facility.
Request facility accessOne search, every participating tissue bank
See real-time availability across suppliers in a single view instead of calling around for stock checks.
Nothing about your contracts changes
Keep purchasing from your facility-approved and contracted tissue banks. AlloPort adds discovery on top; it replaces nothing.
Every supplier is pre-qualified
Only AATB-accredited, FDA-registered tissue banks are onboarded, so compliance is settled before a graft ever appears in your results.
Works with your purchasing software
Secure integration on both sides, compatible with virtually any inventory management or purchasing system you already run.
The right graft at the right time
Find a hard-to-source size or type without a week of phone calls — and get it shipped straight from the tissue bank that has it.
The market data this industry has never had.
Participating tissue banks receive quarterly reports on market behaviour at the product-category level. Not just a way to place more allografts — a way to decide what to produce, where to focus, and how to price.
- Refine product strategy and inventory planning
- Target regional sales focus where demand actually is
- Benchmark competitive fees against real market ranges
Charts are illustrative of report structure. Analytics are delivered as aggregate, market-level intelligence — never another tissue bank's confidential data.
A market, not a middleman.
"Direct" and "neutral" are different claims. A platform that curates which tissue banks it carries, or takes possession of tissue, is a distributor with a better website. Here is how the three models actually differ.
| Traditional distributor | Curated marketplace | AlloPort | |
|---|---|---|---|
| Which tissue banks participate | Whoever holds the contract | An invited, curated subset | Any AATB-accredited, FDA-registered tissue bank |
| Who holds the tissue | Distributor warehouses and re-ships | Often consigned or held | The tissue bank. Always. |
| Chain of custody | Multiple handoffs | Varies by listing | Tissue Bank to facility. AlloPort is never in it. |
| Cost to the facility | Built into the price | Varies | None |
| Cost to the tissue bank | Sales layers plus distribution margin | Platform-negotiated terms | A small processing fee, same for all |
| Existing contracts | Replaced by the contract | Often replaced | Untouched — discovery is additive |
| Inventory visibility | Quoted on request | Partial | Real-time, across all participating tissue banks |
| Tissue Bank's own brand presence | None | Limited | Own sales page, credentials and materials |
| Market analytics for tissue banks | None | Rare | Quarterly category-level reporting |
Comparison describes the three prevailing distribution models in the allograft market. Individual companies within each model vary; verify specifics with any vendor before contracting.
Neutrality is a structure, not a slogan.
An exchange earns trust by binding its own hands. These are the structural facts that let a tissue bank list without fear of being outranked, and a facility trust what it sees.
We are not a distributor
AlloPort does not recover, process, warehouse, or private-label tissue, and holds no inventory position. There is no house product for the platform to favour.
We are never in the chain of custody
Tissue Banks keep custody and ship directly to the facility. The graft passes through one pair of hands, not three.
Accreditation is the only entry bar
AATB accreditation and FDA registration qualify you. Not volume, not tenure, not exclusivity. A single-state tissue bank onboards on the same terms as a national one.
One fee, the same for everyone
The same small processing fee applies to every participating tissue bank equally, so no supplier can buy a better position in the market.
Your data is yours, and isolated
Tenant data is fully isolated with no code path that could return another tissue bank's data to your account. We never share, resell, or train external models on what you send us.
Every action is on the record
Administrative actions against your data write an immutable audit record — actor, action, target, metadata — available to you on request.
Built on infrastructure proven in 15 financial markets.
AlloPort runs on a system with a track record in markets where security and accuracy are non-negotiable. Connecting exposes only non-confidential inventory data — stock levels, sizes, and graft identifiers. Patient identifiers and donor records never leave your systems.
Tenant isolation
Enforced at the database layer. No code path returns another tissue bank's data to a query scoped to your account.
Read-only support access
Support staff use read-only "view-as" sessions. Every write attempt is rejected and logged.
Two-factor authentication
TOTP available on every account, with per-device sessions you can list and revoke from your own settings.
Key management
Per-tissue bank API keys are stored as SHA-256 hashes — unrecoverable even by our own engineers — with instant revocation.
Encryption in transit and at rest
TLS 1.2+ in transit, encrypted object storage at rest, and compliance documents served via 15-minute signed URLs — never a public URL.
Immutable audit log
Every administrative action against your data writes a permanent record. Full history available on request.
We are actively aligning our infrastructure and operational controls toward SOC 2 and HIPAA-aligned security practices, including continuous audit logging, role-based access controls, encrypted backups, and formal access review procedures. A mutual Data Protection Agreement is signed before integration begins, with a 72-hour breach-notification commitment.
Takes about an hour of your team's time.
For your products to show current availability, your inventory data needs to flow to the platform automatically. We handle the technical side. You won't be asked to change your software, adopt new systems, or alter your workflows.
Introductory call
One person who knows your systems — IT lead, data manager, whoever looks after your software. Usually an hour or less.
We build the connection
Typically an API: a secure, automatic link between your system and ours. No emails, no uploads, no spreadsheets. If your systems don't work that way, we have other options.
Testing and verification
We take it away, set it up, test it, and come back to you when it's working. Most tissue banks find it simpler than they expect.
You go live
Your sales page, credentials and materials go up, and your live inventory becomes visible to vetted purchasers.
For your IT team: a full Technical Integration Guidelines document is available on request. A mutual Data Protection Agreement is signed before integration begins.
One fee. Same for every tissue bank. None for buyers.
Traditional placement requires multiple layers of sales professionals and manual procurement coordination. AlloPort automates customer communication and basic education instead — which is what makes a single flat fee possible.
There is no fee to your facility for using AlloPort.
- Search live inventory across all participating tissue banks
- Keep every existing contracted supplier relationship
- Integrates with your existing purchasing software
A small processing fee on completed transactions — the same for every participating tissue bank, whatever its size. Full fee schedule shared during onboarding.
- Direct access to vetted surgical purchasers nationwide
- Your own sales page, credentials and marketing materials
- Quarterly market analytics at product-category level
- Automated buyer communication and product education
What does short-dated tissue cost you today?
Grafts that expire unimplanted are the clearest waste in the category — a donor's gift written off as inventory shrink. Move the sliders to size your own exposure and how much of it wider discovery could recover.
Estimated annual value recovered
Value of short-dated grafts that could reach a patient instead of a waste log.
This estimator is illustrative and driven entirely by the values you enter. It is not a forecast, a guarantee of savings, or a claim about any organisation's performance. Recovery rates depend on tissue type, dating, geography and network density.
The things people ask first.
Does AlloPort ever handle the tissue?
What does it cost?
Which tissue banks can list?
Do we have to change how we buy, or leave our current suppliers?
What data does AlloPort access?
How long does onboarding take, and what does it need from us?
What if our inventory system doesn't have an API?
How is our data kept separate from other tissue banks'?
What do the quarterly analytics include?
Who is AlloPort, and why should we trust you?
Built by people who have worked this supply chain.
AlloPort was developed from a deep understanding of the needs of both providers and purchasers of allografts — because many of the people who make up the company have been providers themselves, or have worked in and for tissue banks. We are not outsiders optimising an industry we have only read about.
We have sat on both sides
Members of our team have been clinical providers, and have worked inside and alongside accredited tissue banks. The procurement and fulfilment workflows this platform has to respect are ones we have run ourselves.
We have no stake in who wins
AlloPort is not a tissue bank and not a distributor. We do not recover, process, warehouse, or distribute tissue, and we are never in the chain of custody — so there is no inventory position and no house product for us to favour.
The platform is not a prototype
AlloPort runs on a system with a proven track record across 15 financial markets — environments where security, accuracy and auditability are non-negotiable.
AATB Affiliate Member
Proud to be an Affiliate Member of the Association for Advancing Tissue and Biologics (AATB). Affiliate membership is AATB's category for organisations that support the field without recovering, processing, or distributing tissue — distinct from the tissue bank accreditation held by every bank that lists on AlloPort.
Get connected before the market opens.
Tissue banks and surgical facilities are being onboarded now, so day-one inventory is deep and day-one demand is real. Tell us which side you're on and we'll set up your walkthrough.
Someone from AlloPort will reply within one business day to schedule your walkthrough.